Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial. (2021)
Attributed to:
Design of HIV vaccines that stimulate T cell and NK cell immunity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci150823
PubMed Identifier: 34850742
Publication URI: http://europepmc.org/abstract/MED/34850742
Type: Journal Article/Review
Volume: 131
Parent Publication: The Journal of clinical investigation
Issue: 23
ISSN: 0021-9738